In the ever-evolving field of diabetes management, glucagon-like peptide-1 receptor agonists have emerged as a transformative therapeutic class. Among these, retaglutide, retatrutide, and trizepatide represent novel https://caoimheupto441629.full-design.com/the-emerging-landscape-of-glp-1-receptor-agonists-retaglutide-retatrutide-and-trizepatide-81556835